Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza A (H1N1)”

Showing 19 of 0 results

Early research (Phase 1)Study completedNCT00973895
What this trial is testing

VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old

Who this might be right for
Influenza A Virus, H1N1 SubtypeNovel Swine-Origin
National Institute of Allergy and Infectious Diseases (NIAID) 20
Large-scale testing (Phase 3)Study completedNCT00971906
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 660
Large-scale testing (Phase 3)Study completedNCT01031719
What this trial is testing

Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors

Who this might be right for
H1N1 Influenza VirusInvasive Solid Tumors
Chiltern Pesquisa Clinica Ltda 59
Post-approval studies (Phase 4)Study completedNCT00935194
What this trial is testing

Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1) : Multi-centre, Prospective, Randomized Controlled Study

Who this might be right for
Influenza
Capital Medical University 102
Testing effectiveness (Phase 2)Study completedNCT00956202
What this trial is testing

Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 303
Not applicableStudy completedNCT00965354
What this trial is testing

Mechanisms of Severe Acute Influenza Consortium (MOSAIC)

Who this might be right for
Influenza
Imperial College London 131
Large-scale testing (Phase 3)Study completedNCT01016548
What this trial is testing

Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy

Who this might be right for
LymphomaMultiple MyelomaInfluenza A Virus, H1N1 Subtype
University Health Network, Toronto 42
Early research (Phase 1)Study completedNCT01059617
What this trial is testing

Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults

Who this might be right for
Influenza
GlaxoSmithKline 133
Post-approval studies (Phase 4)UnknownNCT00936013
What this trial is testing

Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study

Who this might be right for
Influenza
Capital Medical University 400
Early research (Phase 1)Study completedNCT04106817
What this trial is testing

Single Ascending Dose Challenge Study to Determine Safety and Reactogenicity of an Influenza Challenge Virus

Who this might be right for
Influenza
WCCT Global 35
Early research (Phase 1)Study completedNCT04044352
What this trial is testing

H1N1v Virus Challenge Study in Healthy Subjects

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 76
Testing effectiveness (Phase 2)Study completedNCT00956046
What this trial is testing

Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 401
Large-scale testing (Phase 3)Study completedNCT01051661
What this trial is testing

Safety and Efficacy of H1N1 Vaccines in Children Aged 6 Months to Less Than 10 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline 6,154
Testing effectiveness (Phase 2)WithdrawnNCT00964951
What this trial is testing

CSL H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT02071329
What this trial is testing

Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge

Who this might be right for
Influenza A
Immune Targeting Systems Ltd 111
Not applicableEnded earlyNCT04810949
What this trial is testing

Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml

Who this might be right for
Covid19Influenza AInfluenza B+1 more
Hospital Clinica Nova 41
Early research (Phase 1)Study completedNCT04146623
What this trial is testing

Safety Study of Live Attenuated Influenza Vaccine, CodaVax, Delivered Via Intranasal Spray

Who this might be right for
Influenza
Codagenix, Inc 33
Not applicableStudy completedNCT01046734
What this trial is testing

Virus Shedding and Environmental Deposition of a Novel Influenza Virus

Who this might be right for
Novel (H1N1) Influenza
University of Nottingham 105
Early research (Phase 1)Study completedNCT03121339
What this trial is testing

Pharmacodynamic Open-Label Trial With VXA-A1.1 Oral H1 Vaccine in Healthy Adults

Who this might be right for
Seasonal Influenza Preventative Vaccine Pharmacodynamics
Vaxart 8

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation